Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DRTS
DatumZeitQuelleÜberschriftSymbolFirma
18/12/202414h30GlobeNewswire Inc.Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayNASDAQ:DRTSAlpha Tau Medical Ltd
17/12/202415h00GlobeNewswire Inc.Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorNASDAQ:DRTSAlpha Tau Medical Ltd
11/12/202414h30GlobeNewswire Inc.Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
06/12/202414h30GlobeNewswire Inc.Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumNASDAQ:DRTSAlpha Tau Medical Ltd
19/11/202422h00GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
13/11/202414h30GlobeNewswire Inc.Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
21/10/202414h30GlobeNewswire Inc.Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeNASDAQ:DRTSAlpha Tau Medical Ltd
10/10/202414h30GlobeNewswire Inc.Alpha Tau Treats First Patient with Recurrent Lung CancerNASDAQ:DRTSAlpha Tau Medical Ltd
20/09/202414h30GlobeNewswire Inc.Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCNASDAQ:DRTSAlpha Tau Medical Ltd
22/08/202414h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
22/08/202414h30GlobeNewswire Inc.Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConNASDAQ:DRTSAlpha Tau Medical Ltd
14/08/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
14/08/202422h02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
14/08/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
25/06/202414h30GlobeNewswire Inc.Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersNASDAQ:DRTSAlpha Tau Medical Ltd
21/05/202414h45GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/05/202422h01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
13/05/202414h30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSAlpha Tau Medical Ltd
06/05/202414h30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
01/05/202414h30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
25/03/202413h50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
26/02/202414h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
26/02/202414h30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/12/202315h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
20/12/202315h15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
18/12/202317h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202314h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTS